Cleo ALA at cash so not much downside imo with lots of upside in front of it
BNE repost of what Chairman said to a poster Vestro see threads for more info
"Given we are entering a proposed Human Clinical Trial it would be fair to conclude we may not represent the value of our peers in a similar product development stage (Human Trials). The board are conscious of the level of awareness within the investor community and have initiated measures to provide appropriate third party coverage to outline the new ‘BNE’ story since re capitalisation in January 2014. We expect this to be available in the next 4 - 6 weeks."
I think once they get some research coverage we will see a much better value being attributed to the company
Remember BNE recapped by the same team that did AHZ
